Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1962 1
1963 1
1964 2
1968 1
1971 1
1972 2
1973 1
1976 1
2000 1
2001 2
2002 3
2004 3
2005 3
2006 2
2007 7
2008 14
2009 4
2010 6
2011 8
2012 8
2013 3
2014 3
2015 6
2016 10
2017 10
2018 12
2019 9
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM, Friedman GK, Cassady KA, Markert JM. Foreman PM, et al. Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0. Neurotherapeutics. 2017. PMID: 28265902 Free PMC article. Review.
Oncolytic viruses are designed to selectively target, infect, and replicate in tumor cells, while sparing surrounding normal brain. ...Oncolytic viral therapy for glioma remains promising and will undoubtedly impact the future of patient care....
Oncolytic viruses are designed to selectively target, infect, and replicate in tumor cells, while sparing surrounding normal brain. .
The advent of oncolytic virotherapy in oncology: The Rigvir® story.
Alberts P, Tilgase A, Rasa A, Bandere K, Venskus D. Alberts P, et al. Eur J Pharmacol. 2018 Oct 15;837:117-126. doi: 10.1016/j.ejphar.2018.08.042. Epub 2018 Sep 1. Eur J Pharmacol. 2018. PMID: 30179611 Free article. Review.
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. ...In conclusion, Rigvir is an oncotropic and oncolytic virus for treatment of melanoma; the results will be confirmed and up
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are ap
Recurrent Glioblastoma Treated with Recombinant Poliovirus.
Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD. Desjardins A, et al. N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26. N Engl J Med. 2018. PMID: 29943666 Free PMC article. Clinical Trial.
[Oncolytic coxsackievirus therapy as an immunostimulator].
Miyamoto S, Sagara M, Kohara H, Tani K. Miyamoto S, et al. Rinsho Ketsueki. 2017;58(8):977-982. doi: 10.11406/rinketsu.58.977. Rinsho Ketsueki. 2017. PMID: 28883283 Review. Japanese.
Recently, the active development of oncolytic virotherapy has gathered attention. Enterovirus research seeks to better understand its pathogenicity. ...In this report, we review recent clinical progress in oncolytic virotherapy of CVA21 and clinical development of o …
Recently, the active development of oncolytic virotherapy has gathered attention. Enterovirus research seeks to better understand its …
Senecavirus A.
Segalés J, Barcellos D, Alfieri A, Burrough E, Marthaler D. Segalés J, et al. Vet Pathol. 2017 Jan;54(1):11-21. doi: 10.1177/0300985816653990. Epub 2016 Jul 11. Vet Pathol. 2017. PMID: 27371541 Review.
Senecavirus A (SVA) is the only member of the genus Senecavirus within the family Picornaviridae. This virus was discovered as a serendipitous finding in 2002 (and named Seneca Valley virus 001 [SVV-001]) while cultivating viral vectors in cell culture and has been propose …
Senecavirus A (SVA) is the only member of the genus Senecavirus within the family Picornaviridae. This virus was discovered as a sere …
Oncolytic Seneca Valley Virus: past perspectives and future directions.
Burke MJ. Burke MJ. Oncolytic Virother. 2016 Sep 6;5:81-9. doi: 10.2147/OV.S96915. eCollection 2016. Oncolytic Virother. 2016. PMID: 27660749 Free PMC article. Review.
Seneca Valley Virus isolate 001 (SVV-001) is an oncolytic RNA virus of the Picornaviridae family. It is also the first picornavirus discovered of the novel genus Senecavirus. ...This review summarizes the current knowledge of SVV-001 and what its future as an …
Seneca Valley Virus isolate 001 (SVV-001) is an oncolytic RNA virus of the Picornaviridae family. It is also the first pico
Oncolytic viral therapy.
Inam Ur Rehma S, Haaris SM. Inam Ur Rehma S, et al. J Pak Med Assoc. 2017 Apr;67(4):658. J Pak Med Assoc. 2017. PMID: 28420939 Free article. No abstract available.
Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.
Walton RW, Brown MC, Sacco MT, Gromeier M. Walton RW, et al. J Virol. 2018 Sep 12;92(19):e00879-18. doi: 10.1128/JVI.00879-18. Print 2018 Oct 1. J Virol. 2018. PMID: 29997212 Free PMC article.
This has been shown to reduce overall antitumor efficacy of several proposed oncolytic virus prototypes, presumably by limiting direct cell killing and the ensuing inflammatory profile within the infected tumor. ...
This has been shown to reduce overall antitumor efficacy of several proposed oncolytic virus prototypes, presumably by limiting direc …
Recombinant Poliovirus for Cancer Immunotherapy.
Gromeier M, Nair SK. Gromeier M, et al. Annu Rev Med. 2018 Jan 29;69:289-299. doi: 10.1146/annurev-med-050715-104655. Annu Rev Med. 2018. PMID: 29414253 Free PMC article. Review.
"Oncolytic" viruses, naturally existing or genetically engineered viral agents with cell type-specific propagation in malignant cells, were ostensibly conceived for their tumor cytotoxic properties. ...Coopting oncolytic viral agents to instigate antitumor immunity …
"Oncolytic" viruses, naturally existing or genetically engineered viral agents with cell type-specific propagation in malignant cells …
[Oncolytic enteroviruses].
Chumakov PM, Morozova VV, Babkin IV, Baĭkov IK, Netesov SV, Tikunova NV. Chumakov PM, et al. Mol Biol (Mosk). 2012 Sep-Oct;46(5):712-25. Mol Biol (Mosk). 2012. PMID: 23156670 Review. Russian.
Human enteroviruses are one of the most convenient sources to generate oncolytic viruses. Many of enteroviruses are non-pathogenic for humans or cause mild disease. ...This review focuses on the main members of Enterovirus genus, such as Coxsackieviruses, and vaccine strai …
Human enteroviruses are one of the most convenient sources to generate oncolytic viruses. Many of enteroviruses are non-pathogenic fo …
121 results
Jump to page
Feedback